These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 25608633)

  • 21. Regulation of cell proliferation by intermediate-conductance Ca2+-activated potassium and volume-sensitive chloride channels in mouse mesenchymal stem cells.
    Tao R; Lau CP; Tse HF; Li GR
    Am J Physiol Cell Physiol; 2008 Nov; 295(5):C1409-16. PubMed ID: 18815226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The correlation between microRNA490-3p and TGFα in endometrial carcinoma tumorigenesis and progression.
    Sun KX; Chen Y; Chen S; Liu BL; Feng MX; Zong ZH; Zhao Y
    Oncotarget; 2016 Feb; 7(8):9236-49. PubMed ID: 26843615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complementary roles of KCa3.1 channels and β1-integrin during alveolar epithelial repair.
    Girault A; Chebli J; Privé A; Trinh NT; Maillé E; Grygorczyk R; Brochiero E
    Respir Res; 2015 Sep; 16(1):100. PubMed ID: 26335442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effects of candesartan on KCa3.1 potassium channel expression and cell culture and proliferation in peripheral blood CD4
    Li H; Zhao JL; Zhang YM; Han SX
    Clin Exp Hypertens; 2018; 40(4):303-311. PubMed ID: 29388859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The potassium channel KCa3.1 as new therapeutic target for the prevention of obliterative airway disease.
    Hua X; Deuse T; Chen YJ; Wulff H; Stubbendorff M; Köhler R; Miura H; Länger F; Reichenspurner H; Robbins RC; Schrepfer S
    Transplantation; 2013 Jan; 95(2):285-92. PubMed ID: 23325003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium-dependent potassium channels control proliferation of cardiac progenitor cells and bone marrow-derived mesenchymal stem cells.
    Vigneault P; Naud P; Qi X; Xiao J; Villeneuve L; Davis DR; Nattel S
    J Physiol; 2018 Jun; 596(12):2359-2379. PubMed ID: 29574723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Abnormal expression of APRIL in colorectal cancer cells promotes tumor growth and metastasis].
    Wang GH; Lu MH; Wang JC; Wang F; Ding WF; Wang YG; Ju SQ; Wang HM
    Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):249-55. PubMed ID: 23985251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo.
    D'Alessandro G; Catalano M; Sciaccaluga M; Chece G; Cipriani R; Rosito M; Grimaldi A; Lauro C; Cantore G; Santoro A; Fioretti B; Franciolini F; Wulff H; Limatola C
    Cell Death Dis; 2013 Aug; 4(8):e773. PubMed ID: 23949222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The combined activation of K
    Pillozzi S; D'Amico M; Bartoli G; Gasparoli L; Petroni G; Crociani O; Marzo T; Guerriero A; Messori L; Severi M; Udisti R; Wulff H; Chandy KG; Becchetti A; Arcangeli A
    Br J Cancer; 2018 Jan; 118(2):200-212. PubMed ID: 29161243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KCa3.1 modulates neuroblast migration along the rostral migratory stream (RMS) in vivo.
    Turner KL; Sontheimer H
    Cereb Cortex; 2014 Sep; 24(9):2388-400. PubMed ID: 23585521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ca2+-Activated IK K+ Channel Blockade Radiosensitizes Glioblastoma Cells.
    Stegen B; Butz L; Klumpp L; Zips D; Dittmann K; Ruth P; Huber SM
    Mol Cancer Res; 2015 Sep; 13(9):1283-95. PubMed ID: 26041939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium-gated K
    Tarasov MV; Bystrova MF; Kotova PD; Rogachevskaja OA; Sysoeva VY; Kolesnikov SS
    Pflugers Arch; 2017 Feb; 469(2):349-362. PubMed ID: 28028617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CXCL12-induced glioblastoma cell migration requires intermediate conductance Ca2+-activated K+ channel activity.
    Sciaccaluga M; Fioretti B; Catacuzzeno L; Pagani F; Bertollini C; Rosito M; Catalano M; D'Alessandro G; Santoro A; Cantore G; Ragozzino D; Castigli E; Franciolini F; Limatola C
    Am J Physiol Cell Physiol; 2010 Jul; 299(1):C175-84. PubMed ID: 20392929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High expression of KCa3.1 in patients with clear cell renal carcinoma predicts high metastatic risk and poor survival.
    Rabjerg M; Oliván-Viguera A; Hansen LK; Jensen L; Sevelsted-Møller L; Walter S; Jensen BL; Marcussen N; Köhler R
    PLoS One; 2015; 10(4):e0122992. PubMed ID: 25848765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes.
    Koshy S; Wu D; Hu X; Tajhya RB; Huq R; Khan FS; Pennington MW; Wulff H; Yotnda P; Beeton C
    PLoS One; 2013; 8(10):e76740. PubMed ID: 24146918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence of Decreased Activity in Intermediate-Conductance Calcium-Activated Potassium Channels During Retinoic Acid-Induced Differentiation in Motor Neuron-Like NSC-34 Cells.
    Chen PC; Ruan JS; Wu SN
    Cell Physiol Biochem; 2018; 48(6):2374-2388. PubMed ID: 30114691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immature human dendritic cells enhance their migration through KCa3.1 channel activation.
    Crottès D; Félix R; Meley D; Chadet S; Herr F; Audiger C; Soriani O; Vandier C; Roger S; Angoulvant D; Velge-Roussel F
    Cell Calcium; 2016 Apr; 59(4):198-207. PubMed ID: 27020659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered K
    Seo CH; Cui HS; Kim JB
    Transl Res; 2021 Oct; 236():133-146. PubMed ID: 33905948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to alkalinization-induced vascular calcification in vitro.
    Bai Y; Xu J; Yang S; Zhang H; He L; Zhou W; Cheng M; Zhang S
    J Clin Lab Anal; 2021 Aug; 35(8):e23854. PubMed ID: 34313357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intermediate-conductance Ca2+-activated K+ channel, KCa3.1, as a novel therapeutic target for benign prostatic hyperplasia.
    Ohya S; Niwa S; Kojima Y; Sasaki S; Sakuragi M; Kohri K; Imaizumi Y
    J Pharmacol Exp Ther; 2011 Aug; 338(2):528-36. PubMed ID: 21602424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.